Afatinib

Afatinib is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity. Afatinib is a tyrosine kinase receptor inhibitor that is used in the therapy of selected forms of metastatic non-small cell lung cancer

Anant Labs manufacture and furnish high quality Afatinib impurities for global markets. Our Afatinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.